To hear about similar clinical trials, please enter your email below
Trial Title:
Navigating the Clinical Research Process for Lymphoma
NCT ID:
NCT06070246
Condition:
Lymphoma
Conditions: Official terms:
Lymphoma
Conditions: Keywords:
Lymphoma
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
Participation in medical research usually favors a particular demographic group. But
there is limited research available to explain what trial attributes affect the
completion of these specific demographic groups.
This trial will admit a wide range of data on the clinical trial experience of lymphoma
patients to determine which factors prevail in limiting a patient's ability to join or
finish a trial.
It will also try to analyze data from the perspective of different demographic groups to
check for recurring trends which might yield insights for the sake of future lymphoma
patients.
Criteria for eligibility:
Study pop:
Lymphoma patients who are actively considering participating in a clinical trial, but
have not yet completed enrollment and randomization.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Confirmed diagnosis of lymphoma
- Participant must be 18 years of age or older
- Participant must be willing and able to comply with scheduled visits, treatment
schedule, laboratory tests, and other requirements of the study.
Exclusion Criteria:
- Pregnant or lactating woman
- Participant is actively receiving study therapy in another
- Inability to provide written informed consent
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Power Life Sciences
Address:
City:
San Francisco
Zip:
94107
Country:
United States
Contact:
Last name:
Michael B Gill
Phone:
415-900-4227
Email:
https://www.withpower.com/contact-us@withpower.com
Start date:
October 2024
Completion date:
October 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06070246
